Basel Medical Group Ltd Ordinary Shares (BMGL) is a publicly traded Healthcare sector company. As of October 24, 2026, BMGL trades at $4.54 with a market cap of $7.04M and a P/E ratio of 0.00. BMGL moved +0.56% today. Year to date, BMGL is -39.35%; over the trailing twelve months it is -75.82%. Its 52-week range spans $2.56 to $112.80. Rallies surfaces BMGL's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Basel Medical Group closes registered direct offering, raises gross proceeds of US$7.98 million: Basel Medical Group closed a registered direct offering of 6 million units at US$1.33 each, raising US$7.98 million gross and an estimated US$7.28 million net.
| Metric | Value |
|---|---|
| Price | $4.54 |
| Market Cap | $7.04M |
| P/E Ratio | 0.00 |
| EPS | $0.00 |
| Dividend Yield | 0.00% |
| 52-Week High | $112.80 |
| 52-Week Low | $2.56 |
| Volume | 1.63M |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $0 |
| Gross Margin | 0.00% |
BMGL analyst coverage data. Average price target: $0.00.